Media Coverage

Charles River Expands PathoQuest Biologics Testing Partnership, Makes Investment

Scientist at work in laboratory using pipette

FierceBiotech

A year and a half into a strategic partnership using PathoQuest’s next-generation sequencing (NGS) services, Charles River Laboratories appears happy with what it gets and intends to make a direct investment in PathoQuest.

Charles River partnered with PathoQuest in September 2016 to offer clients NGS solutions for biologics viral contamination testing and cell-line genetic characterization, as well as viral safety testing of other materials used in the development of biologics.

Read the Full Article